Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
Open Heart|September 20, 2018
Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM studyDaniela Poli, Emilia Antonucci, Vittorio Pengo, et al.
Thrombosis Research|May 3, 2014
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databasesFrancesco Dentali, Walter Ageno, Elisa Rumi, et al.
Thrombosis Research|October 19, 2024
Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohortNicoletta Erba, Alberto Tosetto, Suha Abdelwahab Abdallah, et al.
Bioorganic & Medicinal Chemistry|November 11, 2008
Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studiesVittoria Colotta, Francesca Capelli, Ombretta Lenzi, et al.
Blood Transfusion = Trasfusione Del Sangue|September 21, 2020
Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register studyMaurizio Margaglione, Emilia Antonucci, Giovanna D'Andrea, et al.
Internal and Emergency Medicine|May 27, 2020
Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolismGualtiero Palareti, Cristina Legnani, Emilia Antonucci, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2010
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolicMassimo Miniati, Claudia Fiorillo, Matteo Becatti, et al.
Internal and Emergency Medicine|June 16, 2026
Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registryFrancesco Del Sole, Tommaso Bucci, Danilo Menichelli, et al.
European Journal of Medicinal Chemistry|October 11, 2016
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypesDaniela Poli, Matteo Falsini, Flavia Varano, et al.
Geroscience|October 22, 2025
Frailty elements, direct oral anticoagulants and mortality risk in atrial fibrillation patients aged ≥ 80 or ≥ 90 years from the nationwide Italian START registry: a propensity score matching analysisDanilo Menichelli, Emilia Antonucci, Daniela Poli, et al.
Pageof 16